ArticleCyclosporine for Recalcitrant Bullous Pemphigoid Induced by Nivolumab Therapy for Malignant MelanomaAuthor:Idy Tam, MDPublish date: July 24, 2024Bullous pemphigoid is a rare dermatologic immune-related adverse event that can occur secondary to anti–programmed death receptor 1 therapy.Read More